Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Olanzapine metabolic side effects: a weight gain issue?

Literature DB >> 18369533

Olanzapine metabolic side effects: a weight gain issue?

Lucia Carulli¹, Fausto Mazzi, Stefania Rondinella, Marco Bertolotti.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2008 PMID： 18369533 DOI： 10.1007/s11739-008-0144-0

Source DB: PubMed Journal: Intern Emerg Med ISSN： 1828-0447 Impact factor: 3.397

Keyword Cloud
References

× No keyword cloud information.

18 in total

1. Olanzapine-induced elevation of plasma triglyceride levels.

Authors: B B Sheitman; P M Bird; W Binz; L Akinli; C Sanchez
Journal: Am J Psychiatry Date: 1999-09 Impact factor: 18.112

Review 2. Consensus development conference on antipsychotic drugs and obesity and diabetes.

Authors:
Journal: Diabetes Care Date: 2004-02 Impact factor: 19.112

Review 3. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.

Authors: Daniel E Casey; Dan W Haupt; John W Newcomer; David C Henderson; Michael J Sernyak; Michael Davidson; Jean-Pierre Lindenmayer; Steven V Manoukian; Mary Ann Banerji; Harold E Lebovitz; Charles H Hennekens
Journal: J Clin Psychiatry Date: 2004 Impact factor: 4.384

4. Hypertriglyceridemia associated with direct effects of olanzapine rather than with weight gain: a case report.

Authors: Courtney Markham-Abedi; Jose de Leon
Journal: J Clin Psychiatry Date: 2006-09 Impact factor: 4.384

5. Olanzapine increases weight and serum triglyceride levels.

Authors: D N Osser; D M Najarian; R L Dufresne
Journal: J Clin Psychiatry Date: 1999-11 Impact factor: 4.384

6. Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects.

Authors: Karen L Houseknecht; Alan S Robertson; William Zavadoski; E Michael Gibbs; David E Johnson; Hans Rollema
Journal: Neuropsychopharmacology Date: 2006-10-11 Impact factor: 7.853

Olanzapine metabolic side effects: a weight gain issue?

1. Olanzapine-induced elevation of plasma triglyceride levels.

Review 2. Consensus development conference on antipsychotic drugs and obesity and diabetes.

Review 3. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.

4. Hypertriglyceridemia associated with direct effects of olanzapine rather than with weight gain: a case report.

5. Olanzapine increases weight and serum triglyceride levels.

6. Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects.

7. Excess mortality of schizophrenia. A meta-analysis.

Review 8. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia.

Review 9. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.

Review 10. Metabolic syndrome and mental illness.